Komal Joshi | Head, IR & Strategic Finance |
Rich Murray | CEO & President |
Beth Trehu | CMO |
Kim Drapkin | CFO |
Debjit Chattopadhyay | H.C. Wainwright |
Colleen Hanley | Baird |
Nick Abbott | Wells Fargo Securities |
Gavin Weiss | J.P. Morgan |
Steve Seedhouse | Raymond James |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Second Quarter 2020 Earnings Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded at the company's request. I'll now turn the call over to your host, Komal Joshi, with Jounce Therapeutics.